Resverlogix is a presenting company at the October 20/21, 2015 BIO Investor Forum in San Francisco. At the AGM, Masila transcribed the following from Don:

"But first, I’m going to touch on the BETonMACE trial. So, the million dollar question – when does the trial start? We are going to announce this trial in full detail on Oct 21st on clinicaltrials.gov. We’re doing that because some of the countries we’re working in need to have the clinicaltrials.gov up and running prior to enrollment. The first two countries we’ll be enrolling in are Israel and Hungary – so stay tuned for that date."

Unfortunately, the BIO investor website does not list the presenting date/time for all companies. So it is unclear right now if Resverlogix presents on 10/20 or 10/21. I sent Sarah an email to clarify. It's also not clear from the above whether enrollment will begin immediately on 10/21 or if the listing of the trial on 10/21 is simply required as the first step for Israel and Hungary to start the enrollment process, which may take more time. But either way, the official listing on clinicaltrials.gov is a huge step forward and I'm looking forward to seeing the published version of the final trial design and get enrollment going.

Best regards,

BearDownAZ